Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hawaii | 29 | 2024 | 2004 | 0.670 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2018 | 744 | 0.670 |
Why?
|
| Cultural Diversity | 2 | 2021 | 187 | 0.650 |
Why?
|
| Body Mass Index | 11 | 2024 | 916 | 0.600 |
Why?
|
| Long QT Syndrome | 2 | 2010 | 15 | 0.550 |
Why?
|
| Insulin Resistance | 1 | 2019 | 199 | 0.530 |
Why?
|
| Glucose Intolerance | 2 | 2007 | 41 | 0.530 |
Why?
|
| Cross-Sectional Studies | 20 | 2024 | 3077 | 0.490 |
Why?
|
| Aging | 3 | 2020 | 764 | 0.480 |
Why?
|
| Electrocardiography | 6 | 2020 | 184 | 0.460 |
Why?
|
| Prevalence | 14 | 2021 | 1597 | 0.440 |
Why?
|
| Middle Aged | 35 | 2020 | 11819 | 0.380 |
Why?
|
| Aged | 25 | 2020 | 7982 | 0.360 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 972 | 0.360 |
Why?
|
| Male | 41 | 2024 | 22779 | 0.360 |
Why?
|
| Adult | 26 | 2024 | 13458 | 0.340 |
Why?
|
| Diabetes Mellitus | 5 | 2009 | 532 | 0.330 |
Why?
|
| Rural Health | 2 | 2007 | 55 | 0.310 |
Why?
|
| Obesity | 6 | 2014 | 1131 | 0.300 |
Why?
|
| Humans | 47 | 2024 | 42163 | 0.300 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 121 | 0.300 |
Why?
|
| Female | 38 | 2024 | 24018 | 0.290 |
Why?
|
| Sweat Glands | 1 | 2007 | 2 | 0.280 |
Why?
|
| Sympathetic Fibers, Postganglionic | 1 | 2007 | 3 | 0.280 |
Why?
|
| Sweating | 1 | 2007 | 5 | 0.280 |
Why?
|
| Risk Factors | 15 | 2020 | 3942 | 0.260 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2006 | 35 | 0.260 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2006 | 31 | 0.260 |
Why?
|
| Acculturation | 2 | 2024 | 203 | 0.250 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 200 | 0.240 |
Why?
|
| Mass Screening | 1 | 2010 | 531 | 0.230 |
Why?
|
| Blood Glucose | 4 | 2009 | 386 | 0.210 |
Why?
|
| Health Status | 2 | 2024 | 432 | 0.200 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 2803 | 0.200 |
Why?
|
| Niacin | 2 | 2013 | 23 | 0.180 |
Why?
|
| Age Factors | 3 | 2019 | 1139 | 0.180 |
Why?
|
| Health Status Disparities | 2 | 2020 | 705 | 0.170 |
Why?
|
| Atrial Flutter | 1 | 2020 | 7 | 0.170 |
Why?
|
| Sleep Apnea, Central | 1 | 2020 | 5 | 0.170 |
Why?
|
| Regression Analysis | 5 | 2010 | 487 | 0.160 |
Why?
|
| Coronary Disease | 1 | 2020 | 123 | 0.160 |
Why?
|
| Autonomic Nervous System | 2 | 2012 | 38 | 0.150 |
Why?
|
| Hypertension | 3 | 2005 | 823 | 0.150 |
Why?
|
| Sex Factors | 4 | 2020 | 1008 | 0.150 |
Why?
|
| Feeding Behavior | 4 | 2009 | 461 | 0.140 |
Why?
|
| Odds Ratio | 4 | 2008 | 587 | 0.140 |
Why?
|
| HIV Infections | 4 | 2013 | 2535 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1051 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1020 | 0.120 |
Why?
|
| Cohort Studies | 7 | 2018 | 1729 | 0.120 |
Why?
|
| Glucose Tolerance Test | 3 | 2015 | 76 | 0.110 |
Why?
|
| Logistic Models | 4 | 2009 | 1001 | 0.110 |
Why?
|
| Blood Pressure | 3 | 2011 | 662 | 0.110 |
Why?
|
| Body Size | 1 | 2014 | 47 | 0.110 |
Why?
|
| Rheumatic Fever | 2 | 2006 | 10 | 0.110 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2007 | 200 | 0.100 |
Why?
|
| World Health Organization | 2 | 2010 | 36 | 0.100 |
Why?
|
| Lipoproteins | 1 | 2013 | 68 | 0.100 |
Why?
|
| Health Surveys | 4 | 2011 | 401 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2006 | 727 | 0.100 |
Why?
|
| Comorbidity | 3 | 2018 | 725 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 502 | 0.090 |
Why?
|
| Japan | 3 | 2011 | 348 | 0.090 |
Why?
|
| Philippines | 3 | 2006 | 80 | 0.090 |
Why?
|
| Adolescent | 8 | 2011 | 5950 | 0.090 |
Why?
|
| Population Surveillance | 2 | 2010 | 245 | 0.090 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2011 | 12 | 0.090 |
Why?
|
| Anti-Retroviral Agents | 1 | 2012 | 158 | 0.090 |
Why?
|
| Proportional Hazards Models | 4 | 2018 | 512 | 0.090 |
Why?
|
| Population Groups | 1 | 2011 | 59 | 0.090 |
Why?
|
| Viremia | 1 | 2011 | 44 | 0.090 |
Why?
|
| Anthropometry | 2 | 2012 | 96 | 0.090 |
Why?
|
| Cellulitis | 1 | 2010 | 6 | 0.090 |
Why?
|
| Methicillin Resistance | 1 | 2010 | 11 | 0.090 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2010 | 10 | 0.080 |
Why?
|
| Adiposity | 1 | 2012 | 155 | 0.080 |
Why?
|
| Community-Acquired Infections | 1 | 2010 | 22 | 0.080 |
Why?
|
| Asia | 2 | 2020 | 99 | 0.080 |
Why?
|
| Life Style | 5 | 2014 | 326 | 0.080 |
Why?
|
| Prejudice | 1 | 2011 | 116 | 0.080 |
Why?
|
| Cholesterol, HDL | 1 | 2010 | 99 | 0.080 |
Why?
|
| Vasodilation | 1 | 2010 | 64 | 0.080 |
Why?
|
| Quality of Life | 2 | 2006 | 599 | 0.080 |
Why?
|
| Diet | 3 | 2014 | 810 | 0.080 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 62 | 0.080 |
Why?
|
| Dietary Fiber | 1 | 2009 | 50 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2011 | 170 | 0.080 |
Why?
|
| Magnesium | 1 | 2009 | 93 | 0.080 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 2009 | 6 | 0.080 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2009 | 18 | 0.080 |
Why?
|
| Sex Distribution | 4 | 2014 | 224 | 0.070 |
Why?
|
| Attitude to Health | 2 | 2014 | 336 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 438 | 0.070 |
Why?
|
| Motor Activity | 1 | 2011 | 438 | 0.070 |
Why?
|
| Adaptation, Psychological | 1 | 2011 | 410 | 0.070 |
Why?
|
| Child, Preschool | 4 | 2024 | 1516 | 0.070 |
Why?
|
| California | 4 | 2011 | 531 | 0.070 |
Why?
|
| Reflex | 1 | 2007 | 29 | 0.070 |
Why?
|
| Energy Intake | 1 | 2008 | 162 | 0.070 |
Why?
|
| Depression | 2 | 2006 | 837 | 0.070 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2007 | 14 | 0.070 |
Why?
|
| Rheumatology | 1 | 2007 | 17 | 0.070 |
Why?
|
| Sampling Studies | 1 | 2006 | 64 | 0.070 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 35 | 0.070 |
Why?
|
| Health Behavior | 1 | 2011 | 568 | 0.060 |
Why?
|
| Introns | 1 | 2006 | 80 | 0.060 |
Why?
|
| Blood Flow Velocity | 2 | 2003 | 88 | 0.060 |
Why?
|
| Axons | 1 | 2007 | 116 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2006 | 92 | 0.060 |
Why?
|
| Gene Frequency | 1 | 2006 | 203 | 0.060 |
Why?
|
| Pediatrics | 1 | 2007 | 69 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2007 | 141 | 0.060 |
Why?
|
| Child | 5 | 2024 | 3381 | 0.060 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2006 | 31 | 0.060 |
Why?
|
| Cultural Characteristics | 1 | 2006 | 128 | 0.060 |
Why?
|
| Rural Population | 2 | 2007 | 352 | 0.060 |
Why?
|
| HIV | 1 | 2006 | 100 | 0.060 |
Why?
|
| Polyomavirus | 1 | 2004 | 3 | 0.060 |
Why?
|
| Virology | 1 | 2004 | 8 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2005 | 60 | 0.060 |
Why?
|
| Young Adult | 3 | 2010 | 4936 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2011 | 641 | 0.060 |
Why?
|
| Pilot Projects | 3 | 2013 | 733 | 0.050 |
Why?
|
| HIV-1 | 1 | 2010 | 747 | 0.050 |
Why?
|
| Venous Insufficiency | 1 | 2003 | 1 | 0.050 |
Why?
|
| Genotype | 1 | 2006 | 796 | 0.050 |
Why?
|
| Leg Ulcer | 1 | 2003 | 8 | 0.050 |
Why?
|
| Leg | 1 | 2003 | 19 | 0.050 |
Why?
|
| Incidence | 3 | 2014 | 1054 | 0.050 |
Why?
|
| Pacific Islands | 1 | 2024 | 121 | 0.050 |
Why?
|
| United States | 4 | 2020 | 5072 | 0.050 |
Why?
|
| Smoking | 2 | 2011 | 1019 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2004 | 323 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2014 | 845 | 0.050 |
Why?
|
| Healthy People Programs | 1 | 2003 | 25 | 0.050 |
Why?
|
| Varicose Veins | 1 | 2002 | 1 | 0.050 |
Why?
|
| Poverty | 1 | 2006 | 395 | 0.050 |
Why?
|
| Virus Replication | 1 | 2004 | 318 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2002 | 33 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2002 | 18 | 0.050 |
Why?
|
| Tea | 1 | 2002 | 46 | 0.050 |
Why?
|
| Catechin | 1 | 2002 | 38 | 0.040 |
Why?
|
| Delayed-Action Preparations | 2 | 2013 | 72 | 0.040 |
Why?
|
| Mortality | 1 | 2003 | 174 | 0.040 |
Why?
|
| Cardiovascular Diseases | 2 | 2005 | 729 | 0.040 |
Why?
|
| Linear Models | 1 | 2002 | 311 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2018 | 1574 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2011 | 162 | 0.040 |
Why?
|
| Cholesterol | 1 | 2020 | 230 | 0.040 |
Why?
|
| Heart Rate | 2 | 2011 | 261 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 362 | 0.030 |
Why?
|
| Los Angeles | 1 | 2018 | 390 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 56 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 69 | 0.030 |
Why?
|
| Ideal Body Weight | 1 | 2014 | 3 | 0.030 |
Why?
|
| Diabetes Complications | 2 | 2006 | 99 | 0.030 |
Why?
|
| Acute Disease | 2 | 2006 | 156 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2006 | 574 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2012 | 34 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2012 | 90 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2015 | 359 | 0.020 |
Why?
|
| Social Support | 2 | 2006 | 438 | 0.020 |
Why?
|
| Infant | 2 | 2007 | 1143 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2006 | 1221 | 0.020 |
Why?
|
| Brachial Artery | 1 | 2010 | 27 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2011 | 89 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2010 | 2485 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 200 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2003 | 541 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2009 | 97 | 0.020 |
Why?
|
| Perception | 1 | 2011 | 209 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 229 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 1586 | 0.020 |
Why?
|
| Polynesia | 1 | 2008 | 7 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 157 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2009 | 253 | 0.020 |
Why?
|
| Social Class | 1 | 2009 | 286 | 0.020 |
Why?
|
| Educational Status | 1 | 2009 | 335 | 0.020 |
Why?
|
| Hospitals, Rural | 1 | 2007 | 25 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2007 | 42 | 0.020 |
Why?
|
| Urban Health | 1 | 2007 | 99 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 638 | 0.020 |
Why?
|
| Tilt-Table Test | 1 | 2006 | 4 | 0.020 |
Why?
|
| Respiration | 1 | 2006 | 56 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 236 | 0.010 |
Why?
|
| Exercise | 1 | 2011 | 674 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 7 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2004 | 29 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 246 | 0.010 |
Why?
|
| Veins | 1 | 2003 | 7 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2003 | 132 | 0.010 |
Why?
|
| Body Image | 1 | 2004 | 87 | 0.010 |
Why?
|
| Varicose Ulcer | 1 | 2002 | 1 | 0.010 |
Why?
|
| Tobacco Use Disorder | 1 | 2006 | 249 | 0.010 |
Why?
|
| Infant Mortality | 1 | 2003 | 64 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 249 | 0.010 |
Why?
|
| Cholesterol, VLDL | 1 | 2002 | 4 | 0.010 |
Why?
|
| Apolipoprotein B-100 | 1 | 2002 | 7 | 0.010 |
Why?
|
| Hydroxycholesterols | 1 | 2002 | 18 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 428 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2002 | 25 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 69 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 64 | 0.010 |
Why?
|
| China | 1 | 2002 | 233 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2002 | 115 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 506 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2003 | 225 | 0.010 |
Why?
|
| Lipids | 1 | 2002 | 256 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 1848 | 0.010 |
Why?
|
| Neoplasms | 1 | 2003 | 1341 | 0.010 |
Why?
|